A National Survey Assessing the Current Workforce of Transplant Pharmacists Across Accredited U.S. Solid Organ Transplant Programs

Taber, David J.; Pilch, Nicole A.; Trofe‐Clark, Jennifer; Kaiser, Tiffany E.

doi:10.1111/ajt.13323

Cited by 24 publications

(39 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, there are several challenges to providing effective pharmaceutical care in the ambulatory care setting, particularly in light of the imbalance between FTEs to patient care needs. A 2015 workforce survey identified that 61% of transplant pharmacist respondents felt understaffed to provide coverage during all phases of a transplant recipient's care . The workflow discrepancy between available pharmacy services and optimal patient care also underscores the need to identify patients at highest risk for DRPs so that pharmacy workflow can be optimized.…”

Section: Discussionmentioning

confidence: 99%

“…A 2015 workforce survey identified that 61% of transplant pharmacist respondents felt understaffed to provide coverage during all phases of a transplant recipient's care. 15 The workflow discrepancy between available pharmacy services and optimal patient care also underscores the need to identify patients at highest risk for DRPs so that pharmacy workflow can be optimized. This study does have several limitations that warrant discussion.…”

Section: Discussionmentioning

confidence: 99%

“…A recently published national workforce survey of transplant pharmacists indicated that 77% of responders have some involvement in the outpatient setting, but this involvement is often limited to the patient's first clinic visit following discharge after transplantation. The identified national median of 1.4 transplant pharmacist full‐time equivalent (FTE) positions (range 0.1–7.1) per 100 transplant recipients does not allow for services spanning all phases of care, but the incorporation of the transplant pharmacist into long‐term ambulatory management has been identified as a goal of the profession …”

mentioning

confidence: 99%

“…The identified national median of 1.4 transplant pharmacist full-time equivalent (FTE) positions (range 0.1-7.1) per 100 transplant recipients does not allow for services spanning all phases of care, but the incorporation of the transplant pharmacist into long-term ambulatory management has been identified as a goal of the profession. 15 At our institution, transplant pharmacists have recently extended coverage to long-term kidney transplant clinics that serve patients who are at least 3 months posttransplantation. Traditionally, pharmacists' roles in the clinic have included completing medication reconciliations, providing patient education and counseling, identifying DRPs, and making therapeutic recommendations to providers.…”

mentioning

confidence: 99%

See 3 more Smart Citations

Development of a Predictive Model for Drug‐Related Problems in Kidney Transplant Recipients

et al. 2017

View full text Add to dashboard Cite

These results demonstrated that a straightforward, 5-minute survey completed by renal transplant recipients prior to their clinic visit may be capable of effectively determining those at risk of having six or more DRPs, potentially allowing use as a screening tool for transplant pharmacists' workflow prioritization. External validation is needed before this tool can be used in the outpatient setting.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Development of a Predictive Model for Drug‐Related Problems in Kidney Transplant Recipients

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Obserwacje prowadzone przez farmaceutów jako członków zespołu w opiece ambulatoryjnej pozwalają zidentyfikować również inne czynniki ryzyka nieprzestrzegania zaleceń przez biorców przeszczepu, np. nadmierne obciążenie finansowe, depresja, izolacja społeczna, co w sytuacji wzrastającego obciążenia lekarza, czyni z farmaceuty kluczowego doradcę [18,20].…”

Section: Tom 74 • Nr 12 • 2018unclassified

Identification of the area of services provided by the clinical pharmacist in patient care after kidney transplantation

Gajda¹,

M²,

Fedorowicz³

et al. 2018

Farm Pol.

View full text Add to dashboard Cite

Identification of the area of services provided by the clinical pharmacist in patient care after kidney transplantation • Kidney transplant is a life-extending treatment of choice in end-stage renal disease. Until November 2018, 805 kidney transplantations from deceased donors were performed in Poland and the waiting list for the kidney transplantation procedure is 1176 patients. Optimal care of the patient focuses on: prevention of rejection and organ loss after transplantation, optimization of immunosuppressive therapy, reduction of side effects and toxicity of medication, prolonging long-term survival, as well as providing more cost-effective therapy and cooperation with the patient to improve compliance and medical adherence. This work identifies and describes the area of services provided by the clinical pharmacist (e.g. medication management, cooperation with the transplant team, patient education) as part of patient care after transplantation. The comprehensive goal of the offered pharmaceutical services is to provide high-quality patient care and increase the effectiveness of pharmacotherapy.

show abstract

Observations from a systematic review of pharmacist‐led research in solid organ transplantation: An opinion paper of the American College of Clinical Pharmacy Immunology/Transplantation Practice and Research Network

Pilch

Park

Lichvar

et al. 2020

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Introduction The contributions of transplant pharmacists to clinical and translational research in the United States are ill‐defined and have not been systematically reviewed. Objectives The American College of Clinical Pharmacy Immunology/Transplantation Practice and Research Network conducted a systematic review of available pharmacist‐led research publications involving solid organ transplantation with the intent to quantify and describe pharmacist‐led research endeavors and their changes over time. Methods An electronic search of Scopus was conducted to identify publications in the field of solid organ transplantation by pharmacist authors between January 1, 1975 and May 25, 2017. Articles were excluded if they were written in non‐English languages or originated from non‐US countries. Review articles, case reports, surveys, basic science research, pre‐clinical studies, and non‐transplant research were further excluded. Studies were categorized as one of four phases on the clinical and translational research spectrum, adapted from the Harvard Clinical and Translational Science Center description of a T1 to T4 classification system. Results A total of 10 354 publications were identified by the systematic search with 547 full‐text English‐language publications included in the analysis. Pharmacists served as the first author in 87% of the articles and as the senior author in 67% of the articles. A total of 71% of the articles included more than one pharmacist author. Transplant pharmacists published more studies that employed a retrospective or observational study design (55% and 78%, respectively). A total of 37% of studies were funded. On the spectrum of clinical and translation research, pharmacists were most involved in T3 (translation to practice) research (72%), followed by T2 (translation to patients) research (23%). Conclusions Transplant pharmacists are increasingly represented in the US literature and frequently published across domains. Further demonstrating the relevance of pharmacist‐delivered interventions and outcomes is a critical area of practice focus.

show abstract

A National Survey Assessing the Current Workforce of Transplant Pharmacists Across Accredited U.S. Solid Organ Transplant Programs

Cited by 24 publications

References 21 publications

Development of a Predictive Model for Drug‐Related Problems in Kidney Transplant Recipients

Development of a Predictive Model for Drug‐Related Problems in Kidney Transplant Recipients

Identification of the area of services provided by the clinical pharmacist in patient care after kidney transplantation

Observations from a systematic review of pharmacist‐led research in solid organ transplantation: An opinion paper of the American College of Clinical Pharmacy Immunology/Transplantation Practice and Research Network

Contact Info

Product

Resources

About